James F. Beck
- Hematology top 1%
- Hematopoietic Stem Cell Transplantation 21
- Acute Myeloid Leukemia Research 13
- Otorhinolaryngology top 2%
- Sinusitis and nasal conditions 12
- Oncology top 2%
- Drug Transport and Resistance Mechanisms 16
- Transplantation top 5%
- Genetics top 5%
-
- Histone Deacetylase Inhibitors Research 17
- Cell death mechanisms and regulation 12
-
- Cystic Fibrosis Research Advances 14
-
- Immune Cell Function and Interaction 13
- Co-authors
- Volker GekelerJürgen SonnemannD. NiethammerPeter BaderKarl H. SandersW IseRupert HandgretingerWolf‐Rüdiger Ulrich
- Journals
- Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (2 papers)Blood (2 papers)
- Partner nations
- GermanyUnited StatesCanada
In The Last Decade
James F. Beck
146 papers receiving 3.9k citations
Peers
Comparison fields: 5 of 127
- Hematology 950
- Otorhinolaryngology 224
- Oncology 1.2k
- Transplantation 93
- Genetics 276
Countries citing papers authored by James F. Beck
This map shows the geographic impact of James F. Beck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James F. Beck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James F. Beck more than expected).
Fields of papers citing papers by James F. Beck
This network shows the impact of papers produced by James F. Beck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James F. Beck. The network helps show where James F. Beck may publish in the future.
Co-authorship network
The 25 scholars most cited alongside James F. Beck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 1 | |
| 3 | 2022 | 1 | |
| 4 | 2022 | 7 | |
| 5 | 2020 | 11 | |
| 6 | 2020 | 15 | |
| 7 | 2012 | 14 | |
| 8 | 2011 | 57 | |
| 9 | 2011 | 21 | |
| 10 | 2010 | 5 | |
| 11 | 2008 | 53 | |
| 12 | Comparative evaluation of the treatment efficacy of suberoylanilide hydroxamic acid (SAHA) and paclitaxel in ovarian cancer cell lines and primary ovarian cancer cells from patients | 2006 | 1 |
| 13 | 2005 | 28 | |
| 14 | 2004 | 74 | |
| 15 | Induction of drug resistance and protein kinase C genes in A2780 ovarian cancer cells after incubation with antineoplastic agents at sublethal concentrations. | 2003 | 23 |
| 16 | 2003 | 25 | |
| 17 | Altered expression of resistance associated genes in hepatoblastoma xenografts incorporated into mice following treatment with adriamycin or cisplatin. | 1998 | 29 |
| 18 | 1998 | 41 | |
| 19 | 1998 | 52 | |
| 20 | Protein kinase C isoenzymes, p53, accumulation of rhodamine 123, glutathione-S-transferase, topoisomerase II and MRP in multidrug resistant cell lines. | 1996 | 12 |
About James F. Beck
James F. Beck is a scholar working on Otorhinolaryngology, Hematology and Oncology, having authored 150 papers that have together received 3.9k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (21 papers), Histone Deacetylase Inhibitors Research (17 papers), Drug Transport and Resistance Mechanisms (16 papers), Cystic Fibrosis Research Advances (14 papers), Acute Myeloid Leukemia Research (13 papers), Immune Cell Function and Interaction (13 papers), Cell death mechanisms and regulation (12 papers) and Sinusitis and nasal conditions (12 papers). The work is most often cited by research in Hematology (950 citations), Otorhinolaryngology (224 citations) and Oncology (1.2k citations). James F. Beck has collaborated with scholars based in Germany, United States and Canada. Frequent co-authors include Volker Gekeler, Jürgen Sonnemann, D. Niethammer, Peter Bader, Karl H. Sanders, W Ise, Rupert Handgretinger, Wolf‐Rüdiger Ulrich, Bernd Gruhn and Jochen G. Mainz. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.